A randomized study on the effects of intramuscular injections with urinary gonadotrophins (Humegon or Pergonal) on pain, local redness and fever in infertile women opting for in-vitro fertilization.
The objective of this open, multicentre, randomized controlled study in women opting for in-vitro fertilization was to compare the occurrence of pain and redness at the injection site and of post-injection fever after i.m. injection with Humegon (n = 89) or Pergonal (n = 92). Assessments were scoring of pain and redness at the injection site and of post-injection fever during the next 24 h using self-administered questionnaires. Injection site pain was reported in 48.9% of injections with Humegon and in 44.9% with Pergonal (P = 0.45). A trend was seen towards more redness after Pergonal injection (24.0 versus 15.5%; P = 0.08). Post-injection fever was reported in 1.4% with Humegon and in 1.1% with Pergonal (P = 0.80). It was concluded that there are no statistically significant differences between Humegon and Pergonal after i.m. injection with respect to the prevalence of pain and redness at the injection site and of post-injection fever.
Verhoeff
A
A
Department of Obstetrics and Gynecology, Zuiderziekenhuis, Rotterdam, The Netherlands.
Schmoutziguer
A P
AP
Doesburg
W H
WH
Gan
R A
RA
Geurts
T B
TB
D000328:Adult; D004890:Erythema / Q000209:etiology*; D005260:Female; D005300:Fertility Agents, Female / Q000009:adverse effects; D005307:Fertilization in Vitro; D005334:Fever / Q000139:chemically induced*; D006801:Humans; D007273:Injections, Intramuscular; D008596:Menotropins / Q000008:administration & dosage / Q000009:adverse effects*; D010146:Pain; D011795:Surveys and Questionnaires
D005300:Fertility Agents, Female; D008596:Menotropins